RRIGX | VIHAX | RRIGX / VIHAX | |
Total Expense Ratio | 1.33 | 0.17 | 782% |
Annual Report Gross Expense Ratio | 1.33 | 0.17 | 782% |
Fund Existence | 23 years | 9 years | - |
Gain YTD | 23.905 | 17.445 | 137% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.2B | 11B | 138% |
Annual Yield % from dividends | 1.72 | 4.14 | 42% |
Returns for 1 year | 23.96 | 16.60 | 144% |
Returns for 3 years | 63.27 | 38.44 | 165% |
Returns for 5 years | 95.76 | 65.48 | 146% |
Returns for 10 years | 61.94 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPEM | 42.32 | 0.12 | +0.28% |
SPDR® Portfolio Emerging Markets ETF | |||
GNOM | 8.36 | -0.03 | -0.36% |
Global X Genomics & Biotechnology ETF | |||
NTSI | 40.22 | -0.23 | -0.56% |
WisdomTree International Efficnt Cr ETF | |||
SCHY | 26.88 | -0.18 | -0.67% |
Schwab International Dividend Equity ETF | |||
MPV | 19.15 | -0.28 | -1.44% |
Barings Participation Investors |